文献速递肝病

振动控制瞬时弹性成像评估非酒精性脂肪性肝病患者纤维化与脂肪变

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-04-26

这项前瞻性多中心研究纳入393例非酒精性脂肪性肝病成人患者,在肝组织学分析后1年内接受振动控制瞬时弹性成像检查,评估其诊断纤维化和脂肪变的准确性。结果显示肝硬度值鉴别进展期纤维化的AUROC为0.83,鉴别肝硬化为0.93;受控衰减参数检测脂肪变的AUROC为0.76。振动控制瞬时弹性成像在区分较低纤维化分期、较高脂肪变分级或非酒精性脂肪性肝炎存在方面准确性较低。

要点

  • 肝硬度值6.5 kPa可排除进展期纤维化,阴性预测值为0.91。
  • 肝硬度值12.1 kPa可排除肝硬化,阴性预测值为0.99。
  • 振动控制瞬时弹性成像区分较低纤维化分期、较高脂肪变分级或非酒精性脂肪性肝炎存在时准确性较低。

核心结论

  • 在非酒精性脂肪性肝病成人患者的前瞻性研究中,以肝组织学为参考标准,振动控制瞬时弹性成像能准确区分进展期与较早阶段纤维化。

研究设计与样本

  • 前瞻性研究纳入393例非酒精性脂肪性肝病患者,在肝组织学分析后1年内接受振动控制瞬时弹性成像检查,中位时间49天(四分位距25-78天),研究时间为2014年7月1日至2017年7月31日。
  • 采用交叉验证的受试者工作特征曲线下面积分析确定纤维化分期两两比较的肝硬度值截断值和脂肪变分级两两比较的受控衰减参数截断值,诊断统计量在敏感度固定为90%和特异度固定为90%时计算。

主要发现

  • 肝硬度值识别进展期纤维化的AUROC为0.83(95%CI 0.79-0.87),识别肝硬化的AUROC为0.93(95%CI 0.90-0.97)。
  • 在固定敏感度下,肝硬度值截断值6.5 kPa排除进展期纤维化的阴性预测值为0.91,截断值12.1 kPa排除肝硬化的阴性预测值为0.99。
  • 在固定特异度下,肝硬度值识别进展期纤维化的阳性预测值为0.71,识别肝硬化的阳性预测值为0.41。
  • 受控衰减参数分析检测脂肪变的AUROC为0.76(95%CI 0.64-0.87)。
  • 振动控制瞬时弹性成像在区分较低纤维化分期、较高脂肪变分级或非酒精性脂肪性肝炎存在方面准确性较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Vibration-controlled transient elastography (VCTE), which measures liver stiffness, has become an important tool for evaluating patients with nonalcoholic fatty liver disease (NAFLD). We aimed to determine the diagnostic accuracy of VCTE in detection of NAFLD in a multicenter cohort of patients. METHODS: We performed a prospective study of 393 adults with NAFLD who underwent VCTE within 1 year of liver histology analysis (median time, 49 d; interquartile range, 25-78 d), from July 1, 2014, through July 31, 2017. Liver stiffness measurement (LSM) cut-off values for pairwise fibrosis stage and controlled attenuation parameter cut-off values for pairwise steatosis grade were determined using cross-validated area under the receiver operating characteristics curve (AUROC) analyses. Diagnostic statistics were computed at a sensitivity fixed at 90% and a specificity fixed at 90%. RESULTS: LSM identified patients with advanced fibrosis with an AUROC of 0.83 (95% CI, 0.79- 0.87) and patients with cirrhosis with an AUROC of 0.93 (95% CI, 0.90-0.97). At a fixed sensitivity, a cut-off LSM of 6.5 kPa excluded advanced fibrosis with a negative predictive value of 0.91, and a cut-off LSM of 12.1 kPa excluded cirrhosis with a negative predictive value of 0.99. At a fixed specificity, LSM identified patients with advanced fibrosis with a positive predictive value of 0.71 and patients with cirrhosis with a positive predictive value of 0.41. Controlled attenuation parameter analysis detected steatosis with an AUROC of 0.76 (95% CI, 0.64-0.87). In contrast, the VCTE was less accurate in distinguishing lower fibrosis stages, higher steatosis grades, or the presence of NASH. CONCLUSIONS: In a prospective study of adults with NAFLD, we found VCTE to accurately distinguish advanced vs earlier stages of fibrosis, using liver histology as the reference standard.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Siddiqui MS, Vuppalanchi R, Van Natta ML, et al. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2018. PMID: 29705261. doi:10.1016/j.cgh.2018.04.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。